CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins83% CONFIDENCEOverall confidence: 83%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better
AJMC[1] and Novo Nordisk's release report the FDA approval announced 5 December 2017.On 5 December 2017 the US FDA approved Ozempic (semaglutide 0.5 mg and 1 mg, once weekly) for adults with type 2 diabetes, the first brand in the semaglutide line that later produced Wegovy and the Wegovy pill.
1.00